Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease.
Ontology highlight
ABSTRACT: Initial recruitment of leukocytes in inflammation associated with diseases such as multiple sclerosis (MS), ischemic stroke, and HIV-related dementia, takes place across intact, but activated brain endothelium. It is therefore undetectable to symptom-based diagnoses and cannot be observed by conventional imaging techniques, which rely on increased permeability of the blood-brain barrier (BBB) in later stages of disease. Specific visualization of the early-activated cerebral endothelium would provide a powerful tool for the presymptomatic diagnosis of brain disease and evaluation of new therapies. Here, we present the design, construction and in vivo application of carbohydrate-functionalized nanoparticles that allow direct detection of endothelial markers E-/P-selectin (CD62E/CD62P) in acu
SUBMITTER: van Kasteren SI
PROVIDER: S-EPMC2607245 | biostudies-literature | 2009 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA